Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc.

Strongbridge Biopharma

TREVOSE, PA — Strongbridge Biopharma plc (NASDAQ: SBBP) today announced that the High Court of Ireland has set the date of the final court hearing to sanction the proposed acquisition of Strongbridge by Xeris Pharmaceuticals, Inc. by means of scheme of arrangement under Chapter 1 of Part 9 of the Irish Companies Act 2014.

The court hearing to sanction the Scheme is scheduled to be heard in the Commercial List of the Court sitting at the Four Courts, Inns Quay, Dublin 7, Ireland at 11:00 a.m. (Irish time) on October 5, 2021, and the Scheme is expected to take effect on or about that date.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.